Legal Disclaimer
This page provides general legal orientation for New Zealand, not legal advice. Regulations change frequently. Always verify current rules with Medsafe and consult a qualified professional.
Peptide Legal Status in New Zealand
New Zealand regulates medicines under the Medicines Act 1981, with Medsafe as the primary regulatory authority. GLP-1 agonists are approved and available by prescription. Medsafe has issued public warnings about purchasing medicines online and the dangers of unregulated products. The regulatory framework is similar to Australia's TGA, though generally less enforcement-heavy.
Regulator
Medsafe (New Zealand Medicines and Medical Devices Safety Authority) — Official website
Key Facts
Compounding Pharmacy Rules
Telehealth Prescribing
Peptide Categories in New Zealand
Approved
Semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro), liraglutide (Saxenda) — Medsafe-approved, prescription-only. Pharmac manages public funding for some indications (type 2 diabetes).
Research / Unapproved
BPC-157, TB-500, GHRPs — not Medsafe-approved. Importation and sale of unapproved medicines is illegal. Medsafe issues public warnings about online medicine purchases.
Banned / Restricted
Unregistered medicines. Medsafe may seize unapproved imports. Check current scheduling under the Misuse of Drugs Act.
Key Legislation
- Medicines Act 1981
- Misuse of Drugs Act 1975
- Medicines Regulations 1984
Peptides in New Zealand: FAQ
Sources
Medical Disclaimer
This content is for informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment recommendations.
Always consult a qualified healthcare provider before starting, stopping, or modifying any treatment. Do not disregard professional medical advice based on information found on this site.
No claims of therapeutic efficacy are made for substances that are not FDA-approved for the discussed indications. Research citations reflect published findings and do not imply endorsement.
Peptide Laws in Other Countries
Get international legal updates
Stay informed when country-specific legal pages, routing guidance, and safety guidance change.
No spam. Unsubscribe anytime.